| Depression and public health: an overview P Cassano, M Fava Journal of psychosomatic research 53 (4), 849-857, 2002 | 1017 | 2002 |
| Treatments for traumatic brain injury with emphasis on transcranial near-infrared laser phototherapy LD Morries, P Cassano, TA Henderson Neuropsychiatric disease and treatment, 2159-2175, 2015 | 215 | 2015 |
| Tolerability issues during long-term treatment with antidepressants P Cassano, M Fava Annals of Clinical Psychiatry 16 (1), 15-25, 2004 | 210 | 2004 |
| Pramipexole in treatment‐resistant depression: a 16‐week naturalistic study L Lattanzi, L Dell'Osso, P Cassano, S Pini, P Rucci, PR Houck, ... Bipolar Disorders 4 (5), 307-314, 2002 | 193 | 2002 |
| Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis P Cassano, SR Petrie, MR Hamblin, TA Henderson, DV Iosifescu Neurophotonics 3 (3), 031404-031404, 2016 | 182 | 2016 |
| Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri-and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life CN Soares, H Arsenio, H Joffe, B Bankier, P Cassano, LF Petrillo, ... Menopause 13 (5), 780-786, 2006 | 164 | 2006 |
| Pramipexole in treatment‐resistant depression: an extended follow‐up P Cassano, L Lattanzi, F Soldani, S Navari, G Battistini, A Gemignani, ... Depression and anxiety 20 (3), 131-138, 2004 | 144 | 2004 |
| Patterns of structural MRI abnormalities in deficit and nondeficit schizophrenia S Galderisi, M Quarantelli, U Volpe, A Mucci, GB Cassano, G Invernizzi, ... Schizophrenia bulletin 34 (2), 393-401, 2008 | 141 | 2008 |
| Near-infrared photobiomodulation combined with coenzyme Q10 for depression in a mouse model of restraint stress: reduction in oxidative stress, neuroinflammation, and apoptosis F Salehpour, F Farajdokht, P Cassano, S Sadigh-Eteghad, M Erfani, ... Brain research bulletin 144, 213-222, 2019 | 132 | 2019 |
| Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort LL Davis, JA Rush, SR Wisniewski, K Rice, P Cassano, ME Jewell, ... Comprehensive psychiatry 46 (2), 81-89, 2005 | 132 | 2005 |
| Near‐infrared transcranial radiation for major depressive disorder: proof of concept study P Cassano, C Cusin, D Mischoulon, MR Hamblin, L De Taboada, A Pisoni, ... Psychiatry journal 2015 (1), 352979, 2015 | 131 | 2015 |
| Substance use disorder comorbidity in major depressive disorder: a confirmatory analysis of the STAR* D cohort LL Davis, E Frazier, MM Husain, D Warden, M Trivedi, M Fava, P Cassano, ... The American Journal on Addictions 15 (4), 278-285, 2006 | 129 | 2006 |
| Rapid and sustained reductions in current suicidal ideation following repeated doses of intravenous ketamine: secondary analysis of an open-label study DF Ionescu, MB Swee, KJ Pavone, N Taylor, O Akeju, L Baer, M Nyer, ... The Journal of clinical psychiatry 77 (6), 10114, 2016 | 126 | 2016 |
| Penetration profiles of visible and near-infrared lasers and light-emitting diode light through the head tissues in animal and human species: a review of literature F Salehpour, P Cassano, N Rouhi, MR Hamblin, L De Taboada, ... Photobiomodulation, photomedicine, and laser surgery 37 (10), 581-595, 2019 | 125 | 2019 |
| Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation C Cusin, DF Ionescu, KJ Pavone, O Akeju, P Cassano, N Taylor, ... Australian & New Zealand Journal of Psychiatry 51 (1), 55-64, 2017 | 122 | 2017 |
| Transcranial photobiomodulation for the treatment of major depressive disorder. The ELATED-2 pilot trial P Cassano, SR Petrie, D Mischoulon, C Cusin, H Katnani, A Yeung, ... Photomedicine and laser surgery 36 (12), 634-646, 2018 | 121 | 2018 |
| Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms MA Caldieraro, P Cassano Journal of affective disorders 243, 262-273, 2019 | 106 | 2019 |
| PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Depression and Renal Disease E Tossani, P Cassano, M Fava Seminars in dialysis 18 (2), 73-81, 2005 | 104 | 2005 |
| Ropinirole in treatment-resistant depression: a 16-week pilot study P Cassano, L Lattanzi, M Fava, S Navari, G Battistini, M Abelli, ... The Canadian Journal of Psychiatry 50 (6), 357-360, 2005 | 98 | 2005 |
| Inflammatory cytokines in major depressive disorder: A case–control study P Cassano, E Bui, AH Rogers, ZE Walton, R Ross, M Zeng, ... Australian & New Zealand Journal of Psychiatry 51 (1), 23-31, 2017 | 87 | 2017 |
